Uridine adenosine tetraphosphate

• Description :

  Uridine adenosine tetraphosphate (UP4A) is an endothelium-derived vasoconstrictor that primarily acts through the P2X1 receptor and possibly through the P2Y2 and P2Y4 receptors. Uridine adenosine tetraphosphate can be used in the study of cardiovascular diseases[1].

• CAS Number :

  [10527-48-7]

• Product Name Alternative :

  UP4A

• UNSPSC :

  12352005

• Target :

  P2X Receptor

• Related Pathways :

  Membrane Transporter/Ion Channel

• Field of Research :

  Cardiovascular Disease

• Smiles :

  O[C@H]1[C@@H](O)[C@H](N(C=N2)C3=C2C(N)=NC=N3)O[C@@H]1COP(OP(OP(OP(OC[C@@H]4[C@@H](O)[C@@H](O)[C@H](N5C=CC(NC5=O)=O)O4)(O)=O)(O)=O)(O)=O)(O)=O

• Molecular Formula :

  C19H27N7O21P4

• Molecular Weight :

  813.35

• References & Citations :

  [1]Jankowski, et al. "Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor." Nature medicine 11.2 (2005) : 223-227.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported